- Home
- / Beijing Sun-Novo Pharmaceutical Research
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Beijing Sun-Novo Pharmaceutical Research financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥44.3
2024-10-29
Market Capitalization
¥4.9 B
2024-10-29
Revenue
¥1.1 B
FY, 2024
CreditSafe Score
?
Score changed on Jun 13, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 134.4M | 232.8M | 346.2M | 492.4M | 675.3M | 929.7M | 1.1B |
| Cost of goods sold | 77.7M | 126.4M | 175.0M | 230.0M | 301.1M | 403.8M | 537.3M |
| Gross profit | 56.8M | 106.8M | 171.7M | 263.2M | 374.3M | 527.1M | 539.1M |
| Gross profit margin, % | 42.2% | 45.9% | 49.6% | 53.5% | 55.4% | 56.7% | 50.2% |
| Operating expense total | 23.3M | 45.3M | 76.6M | 105.7M | 186.9M | 270.0M | 297.3M |
| Depreciation and amortization | 5.3M | 10.0M | 10.5M | 27.5M | 18.2M | 23.4M | 27.1M |
| EBITDA | 33.5M | 61.4M | 95.1M | 157.4M | 187.5M | 257.1M | 237.2M |
| EBITDA margin, % | 24.9% | 26.4% | 27.5% | 32.0% | 27.8% | 27.6% | 22.1% |
| EBIT | 23.9M | 54.5M | 82.9M | 123.2M | 170.2M | 197.1M | 188.3M |
| EBIT margin, % | 17.8% | 23.4% | 23.9% | 25.0% | 25.2% | 21.2% | 17.5% |
| Interest income | 1.4M | 457.0K | 216.0K | 842.0K | 6.2M | 7.2M | 5.7M |
| Interest expense | 2.1M | 751.0K | 1.0M | 3.6M | 9.7M | 12.2M | 16.1M |
| Pre tax profit | 23.3M | 54.5M | 82.3M | 122.1M | 169.1M | 193.4M | 176.0M |
| Income tax expense | 3.1M | 6.5M | 8.1M | 13.3M | 10.4M | 10.5M | 7.0M |
| Net Income | 20.2M | 47.9M | 74.2M | 108.8M | 158.7M | 182.9M | 169.0M |